Cartesian Therapeutics, Inc. (RNAC)
7.21
+0.27
(+3.89%)
USD |
NASDAQ |
Dec 31, 16:00
7.20
-0.01
(-0.14%)
After-Hours: 20:00
Cartesian Therapeutics EPS Diluted (Quarterly): -1.381 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2638 |
| Cabaletta Bio, Inc. | -0.4387 |
| Arcellx, Inc. | -0.9858 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.90M |
| Revenue (Quarterly) | 0.452M |
| Total Expenses (Quarterly) | 36.35M |
| Enterprise Value | 56.70M |
| Gross Profit Margin (Quarterly) | -97.65% |
| Profit Margin (Quarterly) | -7.94K% |
| Earnings Yield | -35.92% |
| Normalized Earnings Yield | -39.56 |